Patent · US Active

Compositions and methods of treating diabetic retinopathy

US10898516B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2019
Grant dateJan 26, 2021
Priority date
Expiry dateApr 30, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating diabetic retinopathy in a subject in need thereof includes administering to the subject a therapeutically effective amount of one or more agents that act as a trap of reactive aldehydes and/or inhibit diabetes-induced superoxide generation and capillary degeneration regulated by GPCR signaling pathways.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.